<i id='717AE64E8F'><strike id='717AE64E8F'><tt id='717AE64E8F'><pre id='717AE64E8F'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen 
Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry 
Duchenne breakthrough therapy leaves behind pioneering families 
Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
FDA approval of Sarepta Duchenne genetic therapy gives me hope 
David Ricks of Eli Lilly: best biopharma CEO of 2023 
Medicare proposal to cover medical devices draws a mixed reaction 
Medicare drug price negotiation hasn't dried up venture capital 
Tori Bowie and the unacceptable rates of Black maternal death 
EPA limits use of carcinogenic gas for sterilizing medical devices 
DIEP, the 'gold standard' of breast reconstruction, is under threat 
RaDonda Vaught links Vanderbilt hospital issues to patient death 
Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies 
Why health records don't always know when patients are dead 
Moonlake's readout produced a cash windfall. Risks remain 
